Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TAZVERIK
- Tazemetostat and Mosunetuzumab in Untreated Follicular Lymphoma
- A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas
- Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma
- Zandelisib + Tazemetostat in R/R Follicular Lymphoma
- A Study of Tazemetostat (Tazverik) Before Prostatectomy in Men With Prostate Cancer
- A Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma
- Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
- Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer
- Induction Chemotherapy and Tazemetostat for Locally Advanced SMARCB1-deficient Sinonasal Carcinoma
- Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation
- Tazemetostat in Malignant Peripheral Nerve Sheath Tumors
- Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC
- Tazemetostat and Pembrolizumab in Patients With Pembrolizumab- or Nivolumab-Resistant, Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma
- Testing the Addition of the Anti-cancer Drug, Tazemetostat, to the Usual Treatment (Dabrafenib and Trametinib) for Metastatic Melanoma That Has Progressed on the Usual Treatment
- A Two-part Study to Characterize Drug-Drug Interaction Effects on Steady-State Pharmacokinetics of Oral Tazemetostat
Clinical trials list
click for details